4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001193125-25-337052
Chief Legal Officer sold 65,000 shares at $38.70 ($2,515,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kearns Evan Chief Legal Officer | 2025-12-26 | Sale | −65,000 | $38.70 | $2,515,500 | 109,398 | D |
| Open-market sales · 65,000 sh · avg $38.70 · $2,515,500 | |||||||
Loading xslF345X05/ownership.xml…